On the heels of vaccine production and distribution over the past month or so, there has been a lot of talk in the news about Covid variants and what this might mean for infection rates, vaccine implications and what might be next in terms of therapies and treatments. Dom and John examine some of these observations during the 35th episode of “The Weekly Bioanalysis” to discuss a number of the variants around the world and what we know so far.
"The Weekly Bioanalysis" is a podcast dedicated to discussing Bioanalytical news, tools and services related to the Pharmaceutical, Biopharmaceutical and Biomarker industries. Every week, KCAS will bring you another 45-60 minutes of friendly banter between our two finest Senior Scientific Advisors as they chat over coffee and brief themselves on what they've learned about the Bioanalytical world the past week.
The Weekly Bioanalysis is brought to you by KCAS. KCAS is a progressive growing contract research organization of well over 100 talented and dedicated individuals committed to serving our clients and improving health worldwide. Our experienced scientists provide stand-alone bioanalytical services to the Pharmaceutical, Biopharmaceutical, Animal Health and Medical Device industries.
